✦ LIBER ✦

Impact of measurement of infliximab and anti-infliximab antibodies levels in pediatric inflammatory bowel disease

✍ Scribed by Cardile, S.; Costa, A.; Loddo, I.; Morabito, G.; Pidone, C.; Romano, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical implications of variations in a

✍ Casper Steenholdt; Magid Al-khalaf; Jørn Brynskov; Klaus Bendtzen; Ole Ø. Thomse 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

962 Clinical Utility of Measuring Inflix

✍ Waqqas Afif; Edward V. Loftus; William A. Faubion; Karen A. Hanson; William J. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

P569 Clinical correlations of infliximab

✍ Daperno, M.; Lavagna, A.; Fracchia, M.; Guiotto, C.; Germano, L.; Rigazio, C.; E 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 55 KB

Impact of Antibodies to Infliximab on Cl

✍ Nanda, Kavinderjit S; Cheifetz, Adam S; Moss, Alan C 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Safety of infliximab treatment in pediat

✍ Scarbrough, Mark; Calabro, Cheryl; Carpenter, Ellen; Bendorf, Kathy; Friesen, Cr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Mechanisms of action of infliximab in in

✍ S. Danese 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 155 KB